Author: aveak

BioEclipse Therapeutics™ today announced that Goldman Sachs has recognized BioEclipse Co-Founder & CEO, Pamela R. Contag, Ph.D., as one of the 100 Most Intriguing Entrepreneurs of 2018 at the seventh annual Goldman Sachs Builders + Innovators Summit in Santa Barbara, California....

18 October, 2018

For the last 20 years, Pamela Contag has studied cancer. And in that time, the world’s understanding of cancer has changed dramatically. “I remember when people were saying ‘One gene, one protein,” which we now know is wrong,” she told Drug Delivery Business News....

09 August, 2018